Margaret O'Boyle


Thank you for your interest. Before you communicate with one of our attorneys, please note: Any comments our attorneys share with you are general information and not legal advice. No attorney-client relationship will exist between you or your business and O’Melveny or any of its attorneys unless conflicts have been cleared, our management has given its approval, and an engagement letter has been signed. Meanwhile, you agree: we have no duty to advise you or provide you with legal assistance; you will not divulge any confidences or send any confidential or sensitive information to our attorneys (we are not in a position to keep it confidential and might be required to convey it to our clients); and, you may not use this contact to attempt to disqualify O’Melveny from representing other clients adverse to you or your business. By clicking "accept" you acknowledge receipt and agree to all of the terms of this paragraph and our Disclaimer.


Margaret O’Boyle is an intellectual property litigator who focuses on patent litigation with a particular emphasis on representing clients in the pharmaceutical, biological, biotechnology, and chemical arts industries. She assists clients with ANDA patent litigation under the Hatch-Waxman Act, inter partes review proceedings before the Patent Trial and Appeal Board and Federal Circuit Appeals, and patent validity opinions.

Margaret effectively litigates on her clients’ behalf by applying her knowledge of the relevant laws and sciences impacting their matters while keeping their overall business goals in mind.

Honors & Awards

  • Super Lawyers, Rising Star, New York (2017, 2018)


Bar Admissions

  • Connecticut
  • New York

Court Admissions

  • US District Court, Eastern and Southern Districts of New York


  • University of Connecticut, J.D.: Executive Editor, University of Connecticut Public Interest Law Journal
  • Emory University, B.S., Neuroscience and Behavioral Biology

Professional Activities


  • Honorable Judge Lois Bloom, United States Magistrate, Eastern District of New York (Summer 2008)


  • American Intellectual Property Law Association
  • Federal Circuit Bar Association
  • Intellectual Property Owners Association


  • “Gender Pay Gaps White Paper” Intellectual Property Owners Association (October 24, 2018)


  • “Abbreviated New Drug Application (ANDA) with Paragraph IV Certification: Critical Insights in 2015” The Knowledge Group/The Knowledge Congress Live Webcast Series (August 25, 2015)
  • “The Old Girls’ Network: Exploring Which Women’s Initiatives Are Working to Create and Sustain a Robust Life Sciences Network” at American Conference Institute’s 2nd Annual Conference on Women Leaders in Life Sciences Law (July 23, 2015)
  • Represented innovator pharmaceutical company and university in multiple cases against generic companies in ANDA litigations on patents related to anti-HIV treatment (S.D.N.Y.); secured favorable settlement agreement
  • Represented innovator pharmaceutical company against generic company in ANDA litigation on patent related to anti-cholesterol treatment (D.N.J.); won summary judgment on prosecution laches and patent misuse
  • Represented innovator pharmaceutical company in ANDA litigation on patents related to cancer treatment (D.N.J.); secured favorable settlement agreement
  • Represented innovator pharmaceutical company in Federal Circuit appeal of Patent Trial and Review Board inter partes review decision related to patents covering marketed biologics
  • Currently representing innovator pharmaceutical company in multiple litigations against nine generic companies on chemical compound and formulation patents related to a drug marketed for the treatment of multiple myeloma (D. Del.)